| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Septerna, Inc. | SVP, Drug Discovery | Common Stock | 92,911 | $1,677,842 | $18.06 | 10 Nov 2025 | Direct |
| Septerna, Inc. | SVP, Drug Discovery | Stock Option (Right to Buy) | 80,000 | 06 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SEPN | Septerna, Inc. | 06 Feb 2026 | 1 | $0 | 4 | SVP, Drug Discovery | 10 Feb 2026, 19:17 |
| SEPN | Septerna, Inc. | 10 Nov 2025 | 1 | -$63,223 | 4 | SVP, Drug Discovery | 13 Nov 2025, 20:13 |
| SEPN | Septerna, Inc. | 07 Aug 2025 | 1 | $0 | 4 | SVP, Drug Discovery | 11 Aug 2025, 19:03 |
| SEPN | Septerna, Inc. | 24 Oct 2024 | 0 | $0 | 3 | SVP, Drug Discovery | 24 Oct 2024, 21:20 |